- Home
- LCNB vs STRO Comparison
LCNB vs STRO Comparison
Compare LCNB & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCNB
- STRO
- Stock Information
- Founded
- LCNB 1877
- STRO 2003
- Country
- LCNB United States
- STRO United States
- Employees
- LCNB N/A
- STRO N/A
- Industry
- LCNB Major Banks
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LCNB Finance
- STRO Health Care
- Exchange
- LCNB Nasdaq
- STRO Nasdaq
- Market Cap
- LCNB 212.3M
- STRO 172.8M
- IPO Year
- LCNB N/A
- STRO 2018
- Fundamental
- Price
- LCNB $15.83
- STRO $1.87
- Analyst Decision
- LCNB
- STRO Strong Buy
- Analyst Count
- LCNB 0
- STRO 7
- Target Price
- LCNB N/A
- STRO $12.14
- AVG Volume (30 Days)
- LCNB 26.1K
- STRO 1.5M
- Earning Date
- LCNB 01-29-2025
- STRO 11-13-2024
- Dividend Yield
- LCNB 5.77%
- STRO N/A
- EPS Growth
- LCNB N/A
- STRO N/A
- EPS
- LCNB 0.52
- STRO N/A
- Revenue
- LCNB $74,686,000.00
- STRO $160,955,000.00
- Revenue This Year
- LCNB N/A
- STRO N/A
- Revenue Next Year
- LCNB $15.49
- STRO N/A
- P/E Ratio
- LCNB $29.28
- STRO N/A
- Revenue Growth
- LCNB 3.03
- STRO 230.90
- 52 Week Low
- LCNB $12.42
- STRO $1.70
- 52 Week High
- LCNB $17.92
- STRO $6.13
- Technical
- Relative Strength Index (RSI)
- LCNB 36.98
- STRO 25.63
- Support Level
- LCNB $15.51
- STRO $1.70
- Resistance Level
- LCNB $16.84
- STRO $3.01
- Average True Range (ATR)
- LCNB 0.55
- STRO 0.21
- MACD
- LCNB -0.21
- STRO -0.05
- Stochastic Oscillator
- LCNB 22.75
- STRO 11.36
About LCNB LCNB Corporation
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.